Comparison of erector spinae plane block with paravertebral block for thoracoscopic surgery: a meta-analysis of randomized controlled trials

Exploring the Thoracolumbar Interfascial Plane (TLIP) Block as a Novel Approach for Improved Pain Management After Spine Surgery: A Comparative Review

Postoperative pain management following spine surgery remains a significant challenge, often requiring multimodal approaches to achieve adequate analgesia while minimizing side effects. The thoracolumbar interfascial plane (TLIP) block has emerged as a novel regional anesthesia technique for addressing this issue. By targeting the interfascial plane between the erector spinae and quadratus lumborum muscles at the thoracolumbar junction, the TLIP block aims to provide targeted analgesia to the surgical site while reducing systemic opioid requirements. This review explores the anatomy, technique, mechanism of action, and clinical evidence supporting the TLIP block for post-spine surgery pain management. Additionally, it compares the TLIP block with traditional pain management approaches and discusses its implications for clinical practice and future research. Overall, the TLIP block shows promise as an effective and potentially safer alternative for post-spine surgery pain management, potentially improving patient outcomes and enhancing recovery. Further research is warranted to optimize its utilization and comprehensively evaluate its long-term effects.

Efficacy of postoperative analgesia with intravenous paracetamol and mannitol injection, combined with thoracic paravertebral nerve block in post video-assisted thoracoscopic surgery pain: a prospective, randomized, double-blind controlled trial

BACKGROUND

Although video-assisted thoracoscopic surgery (VATS) has advantages of reduced injury and faster healing, patients still endure moderate and severe postoperative pain. Paracetamol and mannitol injection, the first acetaminophen injection in China, has the advantages of convenient administration, rapid onset of action, and no first-pass effect. This aim of this study was to investigate the efficacy of postoperative analgesia with paracetamol and mannitol injection, combined with thoracic paravertebral nerve block (TPVB) in post VATS pain.

METHODS

This study was a single-center, prospective, randomized, double-blind controlled clinical trial. Patients scheduled for VATS were randomly divided into three groups, general anesthesia group (Group C), TPVB group (Group T) and TPVB + paracetamol and mannitol injection group (Group TP). In this study, the primary outcome was determined as visual analog scale (VAS) scores at rest and coughing, the secondary observation outcomes were the first time to use analgesic pump, the total consumption of oxycodone in the analgesic pump, number of effective and total analgesic pump compressions at first 48 h postoperatively, the perioperative consumption of sufentanil, time to extubation, hospital length of stay, urine volume, and the incidence of adverse events.

RESULTS

In a state of rest and cough, patients in the Group TP showed significantly lower VAS pain scores at 1, 12, 24, and 48 postoperative-hour compared with Group C and Group T. Intraoperative sufentanil and postoperative oxycodone consumption, the first time to press analgesic pump, the times of effective and total compressions of patient- controlled analgesia (PCA) were lower than those of the Group C and Group T. Interestingly, urine output was higher in Group TP. There were no differences between the three groups in terms of extubation time, length of hospital stay and adverse effects, indicating that intravenous paracetamol and mannitol injection is an effective and safe perioperative analgesia method.

CONCLUSIONS

Paracetamol and mannitol injection, combined with TPVB may provide important beneficial effects on acute pain control and reduce the consumption of opioid in patients undergoing VATS.

TRIAL REGISTRATION

The trial was registered on Jun 19, 2023 in the Chinese Clinical Trial Registry ( https://www.chictr.org.cn/showproj.html?proj=199315 ), registration number ChiCTR2300072623 (19/06/2023).